Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 16, 2010
http://pennstatehershey.org/cancer Speakers at a historical marker unveiling ceremony discuss the significance of discoveries by two Penn State College of Medicine researchers that led to the development of cervical cancer vaccines for human papillomavirus (HPV), including GARDASIL. Drs. John Kreider and Mary K. Howett are remembered for their groundbreaking work.
The marker reads:
Cervical Cancer Prevention
In the 1980s, College of Medicine researchers led by John Kreider and Mary K. Howett and funded by the Jake Gittlen Cancer Research Foundation perfected a technique for propagating the human papillomavirus (HPV), the primary cause of cervical cancer. This and other lab techniques and materials developed by microbiologists in the College helped lead to vaccines against HPV, the first of which earned FDA approval in 2006.